Gutfleisch, Matthias http://orcid.org/0000-0002-2001-5838
Ester, Oliver http://orcid.org/0000-0003-3412-5605
Aydin, Sökmen http://orcid.org/0000-0001-9791-7517
Quassowski, Martin http://orcid.org/0000-0001-6018-2385
Spital, Georg
Lommatzsch, Albrecht http://orcid.org/0000-0001-9640-4103
Rothaus, Kai http://orcid.org/0000-0002-4288-8795
Dubis, Adam Michael http://orcid.org/0000-0002-5108-2179
Pauleikhoff, Daniel http://orcid.org/0000-0003-3691-291X
Funding for this research was provided by:
Novartis Pharma
Article History
Received: 1 June 2021
Revised: 6 January 2022
Accepted: 11 January 2022
First Online: 22 January 2022
Declarations
:
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Approval for the study was obtained from the local ethics committee at the University of Muenster.
: For this type of study, formal consent is not required.
: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. O. Ester, S. Aydin, M. Quassowski and K. Rothaus declare they have no financial interests. M. Gutfleisch received speaker honoraria from Novartis, Bayer and Zeiss outside the submitted work. G. Spital received speaker honoraria from Zeiss, OD-OS and Allergan outside the submitted work. A. Lommatzsch received speaker honoraria from Novartis, Bayer and Zeiss outside the submitted work. A. M. Dubis has a patent OCT analysis technology pending, and a patent prediction method from retinal imaging pending outside the submitted work. D. Pauleikhoff received speaker honoraria from Bayer, Novartis, Zeiss and Allergan outside the submitted work.